Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al
Case Number:
1:16-cv-01114
Court:
Nature of Suit:
Judge:
Firms
Companies
- Allergan PLC
- Aurobindo Pharma Ltd.
- Forest Laboratories Inc.
- Ironwood Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
-
January 22, 2020
Teva Scores Earliest Generic License For Allergan's Linzess
Allergan PLC and Ironwood Pharmaceuticals Inc. have agreed to give Teva Pharmaceuticals USA a license to sell generic versions of the irritable bowel syndrome medication Linzess in March 2029, winning the earliest launch date of the various companies sued for infringement.
-
December 01, 2016
Allergan Sues Drugmakers Over Linzess Generics
Allergan USA Inc. hit four generic-drug makers with a suit Wednesday in Delaware federal court accusing them of jumping the gun on producing a generic version of its irritable bowel syndrome treatment Linzess.